ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z
  • Abstract Number: PB1248

    U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPS Matter Study) Interim Analysis of the 2010-2019 Birth Cohort

    S. Carpenter1, C. He2, L. Malec3, A. Payne4, M. van den Berg3, C. Watson2, C. Thornburg5

  • Abstract Number: PB0947

    UK EHL Registry: Patient Reported Outcomes Measured by Haemoprefer Patient Treatment Preference and Perception Tool

    P. Chowdary1, S. Shapiro2, Z. Hanif1, N. Chadwick3, C. Tait4, M. Mathias5, S. Mangles6, G. Evans7, B. Myers8, D. Beech9, M. Makris10, K. Talks11, S. Austin12, P. Collins13, E. Chalmers14, E. Phillips15, J. Motwani16, G. Dolan17, C. Hay18, D. Hart19

  • Abstract Number: PB0518

    UK NEQAS for Blood Coagulation D-Dimer Point of Care Testing Programme: A Review of Data

    D.P. Kitchen, L. Brown, S. Munroe-Peart, A. Lowe, I. Jennings, S. Kitchen, I. Walker

  • Abstract Number: OC 08.1

    Ultra High-throughput Screening Assay to Identify New Antiplatelet Drugs with Discriminative Mode of Receptor-dependent Action

    D.I. Fernández1, B.M.E. Tullemans1, I. Provenzalle1, J. van Groningen2, J.W.M. Heemskerk1, H. van den Hurk2, M.J.E. Kuijpers1

  • Abstract Number: PB1100

    Ultrasound Mediated Gene Delivery Targets Liver Sinusoidal Endothelial Cells to Achieve Endothelial-specific Factor VIII Expression

    M. Manson1, C. Campbell1, C.-Y. Chen1, X. Cai1, A. Vander Kooi1, C. Miao1,2

  • Abstract Number: PB0043

    Un Untargeted Lipidomic Analysis Reveals Lactosylceramide as Mediator of Monocyte Migration in Coronary Artery Disease Patients

    S. Fiorelli1, S. Eligini1, A. Anesi2, C.M. Manega1, G. Marenzi1, N. Cosentino1, J.P. Werba1, B. Porro1, V. Cavalca1, E. Tremoli1

  • Abstract Number: PB1183

    Uncharacterised bleeding Disorders Are Associated with Reduced Platelet and Microparticle Thrombin Generation and Decreased Procoagulant Oxidised Phosphatidylcholine

    S.G. Obaji1, D.A. Slatter2, V.J. Tyrrell2, P.V. Jenkins1, V.B. O'Donnell2, P.W. Collins1

  • Abstract Number: PB1209

    Unclassified Bleeding Disorder (UBD)-Bleeding Phenotype and Management

    O. Turan1, A. Epstein1, S. Halimeh2, M. Siebert2, R. Abdul-Kadir1

  • Abstract Number: PB1588

    Uncommon Types of von Willebrand Disease

    P. Birke, D. Pospíšilová

  • Abstract Number: PB2150

    Uncovering Clinical Gaps in Treatment of Cancer-Associated Thrombosis: A Clinical Practice Assessment

    J. Spyropoulos, C. Padbury

  • Abstract Number: PB1426

    Underlying Causes Greatly Influence the Development of HIT Antibodies and Clinical Outcomes in Patients with Heparin-induced Thrombocytopenia

    S. Miyata1,2, K. Kokame2

  • Abstract Number: PB0820

    Unexpected Phenotypic Characteristics Associated with Severe Haemophilia B in Two Paediatric Patients with Deletions Involving the Whole F9 and Contiguous Genes

    P. Radic1, M. Abelleyro1, B. Ziegler1, V.D. Marchione1, K. Waisman1, L. Rossetti1, J. Nevado2, P. Lapunzina2, M. Hepner3, G. Sciuccati3, C.D. De Brasi1,4, M. Bonduel3

  • Abstract Number: PB0681

    Unique Ready to Use, Highly Stable Multiplatform Chromogenic Assays to Facilitate Laboratory Practice

    M. Peyrafitte, C. Dunois, S. Molton, J. Amiral

  • Abstract Number: OC 01.3

    Unraveling the Protective Effects of Factor Xa Inhibition by Rivaroxaban on Atherosclerosis by RNA Sequencing

    J.J. Posma1, R. Van Oerle1, A.C. Cleuren2, M.A. Van der Ent2, A. Isaacs3, M. Stoll4,5, H. Ten Cate1,6, H.M. Spronk1

  • Abstract Number: PB0680

    Updated CLOTSref: A Mobile Application for Standardized Reference Ranges in Developmental Hemostasis

    P.T. Tieu1,2, J. Chung1,2, T.Q.H. Nguyen3, D. Matino1,4, K. Moffat5, A. Chan1,4

  • Abstract Number: PB2435

    Upper Extremities Deep Vein Thrombosis and DOAC Treatment: a Prospective Cohort Study

    M.C. Vedovati1, G. Tratar2, A. Mavri2, L. Pierpaoli3, G. Agnelli1, C. Becattini1

  • Abstract Number: PB2249

    Upregulation of Factor XI in End Stage Renal Disease Is Associated with Increased Thrombin Generation and D-dimer

    D. Hoppensteadt1, P. Maia1, E. Bontekoe1, F. Siddiqui1, V. Bansal2, J. Fareed1

  • Abstract Number: PB0442

    Upregulation of Inflammatory Biomarkers in Pulmonary Embolism as Studied by a Biochip- Array Profiling Approach

    E. Bontekoe, E. Brailovsky, D. Hoppensteadt, F. Siddiqui, A. Farooqui, O. Iqbal, M. Latz, J. Fareed, A. Darki

  • Abstract Number: PB0832

    Uptake of MyABDR in Australia

    S. Parikh1, J. Curtin1,2, T. Carter1,3, S. Brown1,4, R. Prasad1,5, S. Mcrae1,6, H. Tran1,7

  • Abstract Number: PB1474

    Uremia Induced Pre-Activation Results in Platelet Function Impairment in Chronic Kidney Disease

    C. Baaten1, M. Sternkopf1, E. Stamellou2, T. Saritas2, J. Jankowski1,3, J. Floege2, H. Noels1

  • Abstract Number: PB1262

    Use of ‘Virtual Clinics’ Telehealth Model in Pediatric Patients with Hemophilia and Inherited Bleeding Disorders: Experience from a Tertiary Care Center

    M. Saleh1, A. Aljefri2, A. Alkofide2, F. Allehaidan3, B. Abdo3, A. Amao2, B. Safi4, V. Mohammed2

  • Abstract Number: PB2117

    Use of a Cancer Screening Tool as Part of a Conservative Approach to Screening for Occult Malignancy after Unprovoked DVT: The King’s College Hospital Experience

    C. Cox, L. Roberts, S. Guppy, R. Patel, R. Arya, J. Czuprynska

  • Abstract Number: PB1501

    Use of a Whole Exome “Slice” for Evaluation of Inherited Platelet Disorders

    K. Todd Jr.1, W. Zhang2, B. Dawson2, L. Luchtman-Jones1, J. Palumbo1

  • Abstract Number: PB2132

    Use of Anti-Factor Xa Levels in Cancer Patients Taking Direct Oral Anticoagulants

    A. Weatherill1, Z. Sayar1, C. Gates1, M. Thomas1,2

  • Abstract Number: PB1026

    Use of Desmopressin in the Treatment of Bleeding in Non-severe Haemophilia A

    F.R. Kloosterman1, A. Zwagemaker1, E.A.M. Beckers2, J.G. van der Bom3, M. Coppens4, P. Collins5, K. Fischer6, S.C. Gouw1,3, C.R.M. Hay7, M.J.H.A. Kruip8, F.J.M. van der Meer9, K. Meijer10, L. Nieuwenhuizen11, S. Shapiro12, K. Fijnvandraat1

  • Abstract Number: PB2098

    Use of Direct Oral Anticoagulants (DOACs) as Primary or Secondary Prophylaxis of Venous Thromboembolism in Patients with Multiple Myeloma on Immunomodulatory Drugs

    C. Aguilar, A.B. Dueñas, F. Sevil, C. Domínguez

  • Abstract Number: PB2224

    Use of Direct Oral Anticoagulants in Congenital Thrombophilias

    N. Montanez, M. Escobar

  • Abstract Number: PB1332

    Use of Eltrombopag in Children with Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

    G. Lassandro, V. Palladino, A. Amoruso, V.V. Palmieri, C. Pastore, G.C. Del Vecchio, P. Giordano, Italian Association of Pediatric Hematology and Oncology (AIEOP)

  • Abstract Number: PB0964

    Use of Emicizumab Prophylaxis in Adult and Pediatric Hemophilia A Patients with and without Inhibitors: Single Center Experience

    N. Montanez, D. Oldfield, S. Gustafson, J. Larson, N. Rodriguez, N. Menon, D. Brown, M. Escobar

  • Abstract Number: PB0700

    Use of Liquid Low Molecular Weight Heparin Anti-Xa Assay for Detection of Apixaban

    N. De Simone1, F. Compton1, S. Paulino2, W. Tharpe3, M. Johns3, R. Sarode2

  • Abstract Number: PB2500

    Use of Oral Contraceptives (OCs) and Thrombin Generation: Cross-sectional Analysis of the Longitudinal Study of Adult Health (ELSA-Brazil)

    D.R. Rios1, T. Batista1, A.P. Silva1, M.D.G. Carvalho1, C. Maluf2, A.L. Ribeiro2, S. Barreto2, R. de Figueiredo1

  • Abstract Number: PB1265

    Use of Prolong Parenteral Lipid Emulsions in NICU and Hematologic Disorders

    G. Ambreen1, K. Hussain2, M. Sohail3, S. Javed3, U. Iazaz4, K. Aziz Ahmad4, H. Muhammad Waqar3, Z. Naz3, H. Abdul Moiz3, H. Abdul Saboor3

  • Abstract Number: PB0301

    Use of Prothrombin Complex Concentrate for Reversal of Oral Anticoagulants in the Clinical Practice of a Portuguese Tertiary Hospital

    D. Cibele, I. Machado, L. Gonçalves, C. Monteiro, M. Carvalho, C. Koch

  • Abstract Number: PB0291

    Use of Recombinant von Willebrand Factor Alone during Surgeries in Type 2 von Willebrand Patients: Case Reports

    S. Boukhlal1, C. Loeuillet2, V. Cogulet2, H. Galinat3, B. Pan-Petesch4

  • Abstract Number: PB1194

    Use of the ISTH Bleeding Assessement Tool in Diagnosis of Bleeding Disorders in West Algeria

    D. Benlaldj1,2, M.A. Mouedene2

  • Abstract Number: PB0864

    Use of Thromboelastography and Thrombin Generation Assay in a Patient Treated with Emicizumab

    L. Sattler1, A.-C. Gerout2, O. Feugeas3, A. Herb1, L. Grunebaum1, D. Desprez3

  • Abstract Number: PB0327

    Use of Thromboelastography to Monitor Emicizumab in a Patient with Severe Haemophilia A without Inhibitor

    G.L. Tiscia1, F. Cappucci1, A. De Laurenzo1, D. Colaizzo1, G. Favuzzi1, P. Vaira2, A. Ostuni3, M. Margaglione4, E. Grandone1

  • Abstract Number: PB0456

    Usefulness of D-dimers Levels Determination in the Prediction of Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Anticoagulant Therapy

    S. Bounaas

  • Abstract Number: PB1489

    Usefulness of ISTH-BAT in Clinical Assessment of Inherited Platelet Disorders: Experience of the Spanish National Project

    J.M. Bastida1, M.L. Lozano2, A. Marín-Quílez1, L. Tomás-Menor3, T. Sevivas4, A. Rodríguez-Alén5, N. Butta6, N. Fernández-Mosteirin7, C. Aguilar8, N. Bermejo9, C. Sierra10, M. Lozano11, M.F. López-Fernández12, F. Velasco13, M.J. Varo14, M.N. Alonso15, P. Marco3, J.R. González Porras1, A. Cid16, J. Rivera2,17

  • Abstract Number: PB1172

    Usefulness of Tissue Factor-Independent Coagulation Parameters for Monitoring FXI-Concentrate Replacement in Patients with FXI-Deficiency

    D. Bertaggia Calderara, M.G. Zermatten, A. Aliotta, L. Alberio

  • Abstract Number: PB2092

    Using Baseline Characteristics to Differentiate Atrial Fibrillation Prevalence and Incidence in Pulmonary Embolism

    D. Patel, B. Slajus, D. Hoppensteadt, J. Fareed, E. Brailovsky, A. Darki

  • Abstract Number: PB2564

    Utility of Fibrinogen Levels and Rotational Thrombo Elastometry (ROTEM) in Predicting Post Partum Hemorrhage

    J. Kotwal1, S.N. Jan2, G. Mediratta3, H. Khullar3

  • Abstract Number: PB0355

    Utility of Prophylactic Fresh Frozen Plasma Transfusion for Correction of Coagulopathy Prior to Image-Guided Drainage for Infected Collections

    P. Porchezhian1, A. Jain2, U. Gosi3, R. Hans4, J. Ahluwalia5, P. Malhotra2

  • Abstract Number: PB1499

    Utility of the ISTH Bleeding Assessment Tool (BATs) in Diagnosis of Glanzmann Thrombasthenia Patients – Experience from Pakistan

    N. Saqlain

  • Abstract Number: PB1497

    Utility of the ISTH Bleeding Assessment Tool and the Pediatric Bleeding Questionnaire in predicting platelet function defects in pediatric patients with excessive bleeding

    D. Fedorova1, A. Ignatova1, D. Polokhov1, E. Ponomarenko1, E. Seregina1, A. Poletaev1, M. Panteleev2, P. Zharkov1

  • Abstract Number: PB1068

    Utilizing Continuous Factor Infusion Replacement in a Hemophilia B Patient Undergoing Cardiac Surgery

    S. Sewaralthahab1,2, S. Farid1, H. Smith1

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley